S100A4 and malignant colon neoplasm: In one study, METTL1 overexpression increased the lethal impact of cisplatin via the S100A4/p53 pathway on cisplatin-resistant colon cancer cells.50 Another study discovered that METTL1 is frequently amplified and over expressed in malignancies, which is linked to poor patient survival.